Data as of Dec 06
| +0.30 / +1.79%|
The 7 analysts offering 12-month price forecasts for Repros Therapeutics Inc have a median target of 32.00, with a high estimate of 41.00 and a low estimate of 20.00. The median estimate represents a +87.79% increase from the last price of 17.04.
The current consensus among 7 polled investment analysts is to Buy stock in Repros Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.